Quipt Home Medical Corp. (NASDAQ:QIPT – Get Rating) – Analysts at Raymond James dropped their Q3 2024 earnings per share (EPS) estimates for shares of Quipt Home Medical in a research note issued to investors on Tuesday, May 16th. Raymond James analyst R. Sarugaser now expects that the company will post earnings per share of $0.03 for the quarter, down from their prior forecast of $0.10. The consensus estimate for Quipt Home Medical’s current full-year earnings is $0.22 per share. Raymond James also issued estimates for Quipt Home Medical’s Q4 2024 earnings at $0.05 EPS.
Quipt Home Medical (NASDAQ:QIPT – Get Rating) last announced its quarterly earnings data on Monday, February 13th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $40.82 million during the quarter, compared to analysts’ expectations of $41.27 million. Quipt Home Medical had a return on equity of 1.99% and a net margin of 0.86%.
Quipt Home Medical Stock Performance
Shares of QIPT opened at $5.76 on Thursday. Quipt Home Medical has a 12-month low of $3.89 and a 12-month high of $7.26. The firm has a market cap of $240.71 million, a PE ratio of 28.80 and a beta of 0.61. The company’s 50 day simple moving average is $6.40 and its 200-day simple moving average is $5.66. The company has a current ratio of 1.05, a quick ratio of 0.60 and a debt-to-equity ratio of 0.18.
Institutional Trading of Quipt Home Medical
A number of large investors have recently added to or reduced their stakes in the business. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Quipt Home Medical by 13.9% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 33,100 shares of the company’s stock valued at $145,000 after buying an additional 4,050 shares during the period. Acadian Asset Management LLC boosted its position in Quipt Home Medical by 1,709,900.0% in the first quarter. Acadian Asset Management LLC now owns 17,100 shares of the company’s stock valued at $75,000 after buying an additional 17,099 shares in the last quarter. First Manhattan Co. raised its stake in shares of Quipt Home Medical by 56.9% in the first quarter. First Manhattan Co. now owns 951,250 shares of the company’s stock worth $4,175,000 after acquiring an additional 345,000 shares during the last quarter. Royal Bank of Canada raised its stake in shares of Quipt Home Medical by 24.6% in the first quarter. Royal Bank of Canada now owns 12,327 shares of the company’s stock worth $54,000 after acquiring an additional 2,437 shares during the last quarter. Finally, Bank of America Corp DE raised its stake in shares of Quipt Home Medical by 59.8% during the first quarter. Bank of America Corp DE now owns 29,641 shares of the company’s stock worth $130,000 after buying an additional 11,096 shares during the last quarter. 26.14% of the stock is currently owned by institutional investors.
About Quipt Home Medical
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions.
- Get a free copy of the StockNews.com research report on Quipt Home Medical (QIPT)
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.